7bgw
From Proteopedia
(Difference between revisions)
												
			
			m  (Protected "7bgw" [edit=sysop:move=sysop])  | 
				|||
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure'''  | ||
| - | + | ==14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1011==  | |
| + | <StructureSection load='7bgw' size='340' side='right'caption='[[7bgw]], [[Resolution|resolution]] 1.90Å' scene=''>  | ||
| + | == Structural highlights ==  | ||
| + | <table><tr><td colspan='2'>[[7bgw]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7BGW OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7BGW FirstGlance]. <br>  | ||
| + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.9Å</td></tr>  | ||
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=CSO:S-HYDROXYCYSTEINE'>CSO</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene>, <scene name='pdbligand=SEP:PHOSPHOSERINE'>SEP</scene>, <scene name='pdbligand=TLQ:4-(2-phenylimidazol-1-yl)naphthalene-1-carbaldehyde'>TLQ</scene></td></tr>  | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7bgw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7bgw OCA], [https://pdbe.org/7bgw PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7bgw RCSB], [https://www.ebi.ac.uk/pdbsum/7bgw PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7bgw ProSAT]</span></td></tr>  | ||
| + | </table>  | ||
| + | <div style="background-color:#fffaf0;">  | ||
| + | == Publication Abstract from PubMed ==  | ||
| + | The stabilization of protein complexes has emerged as a promising modality, expanding the number of entry points for novel therapeutic intervention. Targeting proteins that mediate protein-protein interactions (PPIs), such as hub proteins, is equally challenging and rewarding as they offer an intervention platform for a variety of diseases, due to their large interactome. 14-3-3 hub proteins bind phosphorylated motifs of their interaction partners in a conserved binding channel. The 14-3-3 PPI interface is consequently only diversified by its different interaction partners. Therefore, it is essential to consider, additionally to the potency, also the selectivity of stabilizer molecules. Targeting a lysine residue at the interface of the composite 14-3-3 complex, which can be targeted explicitly via aldimine-forming fragments, we studied the de novo design of PPI stabilizers under consideration of potential selectivity. By applying cooperativity analysis of ternary complex formation, we developed a reversible covalent molecular glue for the 14-3-3/Pin1 interaction. This small fragment led to a more than 250-fold stabilization of the 14-3-3/Pin1 interaction by selective interfacing with a unique tryptophan in Pin1. This study illustrates how cooperative complex formation drives selective PPI stabilization. Further, it highlights how specific interactions within a hub proteins interactome can be stabilized over other interactions with a common binding motif.  | ||
| - | + | Reversible Covalent Imine-Tethering for Selective Stabilization of 14-3-3 Hub Protein Interactions.,Cossar PJ, Wolter M, van Dijck L, Valenti D, Levy LM, Ottmann C, Brunsveld L J Am Chem Soc. 2021 Jun 9;143(22):8454-8464. doi: 10.1021/jacs.1c03035. Epub 2021 , May 28. PMID:34047554<ref>PMID:34047554</ref>  | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>  | |
| - | [[Category:   | + | </div>  | 
| + | <div class="pdbe-citations 7bgw" style="background-color:#fffaf0;"></div>  | ||
| + | |||
| + | ==See Also==  | ||
| + | *[[14-3-3 protein 3D structures|14-3-3 protein 3D structures]]  | ||
| + | == References ==  | ||
| + | <references/>  | ||
| + | __TOC__  | ||
| + | </StructureSection>  | ||
| + | [[Category: Homo sapiens]]  | ||
| + | [[Category: Large Structures]]  | ||
| + | [[Category: Cossar PJ]]  | ||
| + | [[Category: Dijck Lv]]  | ||
| + | [[Category: Ottmann C]]  | ||
| + | [[Category: Wolter M]]  | ||
Current revision
14-3-3 sigma with Pin1 binding site pS72 and covalently bound LvD1011
  | |||||||||||
